UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S. healthcare investment firm

London, and New York, NY, 21 July 2020 – UCL Business (UCLB) and Apollo Therapeutics (Apollo), a pioneering collaboration between three global pharmaceutical companies and three...

Opening new pathways for bioprocessing

A pivotal link between industry and academia, Teesside University’s £22m National Horizons Centre (NHC) opened last September with two very clear objectives. One is to...

Driving innovation

As one of the leading technology transfer companies, UCLB’s mission is to benefit both the economy and society as a whole by commercialising the...

UK STRIDES INTO INTERNATIONAL ARENA OF VACCINE DEVELOPMENT

As Oxford University and Imperial College London move into poll position in the race to develop an anti-Covid vaccine, the UK’s first dedicated Vaccines...